Leon Chang

1.6k total citations
23 papers, 1.3k citations indexed

About

Leon Chang is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Leon Chang has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 9 papers in Molecular Biology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Leon Chang's work include Cannabis and Cannabinoid Research (11 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Pain Mechanisms and Treatments (5 papers). Leon Chang is often cited by papers focused on Cannabis and Cannabinoid Research (11 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Pain Mechanisms and Treatments (5 papers). Leon Chang collaborates with scholars based in United States, Australia and Belgium. Leon Chang's co-authors include Sandra R. Chaplan, Douglas W. Bonhaus, J. Guy Breitenbucher, Gladys Martin, James A. Palmer, Michael Webb, Lin Luo, Sandy J. Wilson, Ann Barbier and Steven W. Sutton and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Neuroscience.

In The Last Decade

Leon Chang

22 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leon Chang United States 14 639 534 493 334 131 23 1.3k
Pietro Marini Italy 20 885 1.4× 487 0.9× 424 0.9× 212 0.6× 47 0.4× 45 1.5k
Oscar Sasso Italy 22 943 1.5× 382 0.7× 492 1.0× 491 1.5× 97 0.7× 27 1.7k
Barbara Malinowska Poland 27 1.0k 1.6× 591 1.1× 719 1.5× 376 1.1× 105 0.8× 120 2.3k
Xavier Nadal Spain 18 841 1.3× 767 1.4× 461 0.9× 478 1.4× 66 0.5× 20 1.5k
Jenny L. Wilkerson United States 21 766 1.2× 439 0.8× 328 0.7× 443 1.3× 99 0.8× 53 1.4k
Gunnar Tiger Sweden 22 973 1.5× 590 1.1× 317 0.6× 163 0.5× 179 1.4× 50 1.4k
Susanna Tchilibon United States 16 1.6k 2.6× 861 1.6× 466 0.9× 186 0.6× 125 1.0× 18 2.2k
Sherry Shu‐Jung Hu Taiwan 16 727 1.1× 339 0.6× 185 0.4× 135 0.4× 90 0.7× 22 972
Sharon Anavi‐Goffer United Kingdom 13 1.1k 1.7× 673 1.3× 348 0.7× 139 0.4× 53 0.4× 21 1.4k
Jesse LoVerme United States 11 1.2k 1.8× 411 0.8× 420 0.9× 428 1.3× 124 0.9× 12 1.7k

Countries citing papers authored by Leon Chang

Since Specialization
Citations

This map shows the geographic impact of Leon Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leon Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leon Chang more than expected).

Fields of papers citing papers by Leon Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leon Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leon Chang. The network helps show where Leon Chang may publish in the future.

Co-authorship network of co-authors of Leon Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Leon Chang. A scholar is included among the top collaborators of Leon Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leon Chang. Leon Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Leon, Brian L. Knight, Jocelyn Sendecki, et al.. (2024). P626 JNJ-77242113, an oral peptide selectively targeting the IL-23 receptor, demonstrates pharmacodynamic activity in rat and human colon tissue explants following oral dosing. Journal of Crohn s and Colitis. 18(Supplement_1). i1193–i1193. 2 indexed citations
2.
Chang, Leon, Jocelyn Sendecki, Jonathan Sherlock, et al.. (2024). Su1738 JNJ-77242113, AN ORAL PEPTIDE SELECTIVELY TARGETING THE IL-23 RECEPTOR, DEMONSTRATES PHARMACODYNAMIC ACTIVITY IN RAT AND HUMAN COLON TISSUE EXPLANTS FOLLOWING ORAL DOSING. Gastroenterology. 166(5). S–791. 1 indexed citations
3.
Lee, Ming-Chin, Leon Chang, Carl L. Manthey, et al.. (2024). IL-23 regulation of myeloid cell biology during inflammation. Cytokine. 179. 156619–156619. 1 indexed citations
4.
Lee, Ming-Chin, Leon Chang, Carl L. Manthey, et al.. (2024). The mode of action of IL-23 in experimental inflammatory arthritic pain and disease. Arthritis Research & Therapy. 26(1). 148–148. 5 indexed citations
5.
Keith, John M., W. M. Jones, Mark Seierstad, et al.. (2020). Heteroarylureas with fused bicyclic diamine cores as inhibitors of fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry Letters. 30(20). 127463–127463. 4 indexed citations
6.
Blevitt, Jonathan M., Michael D. Hack, Krystal Herman, et al.. (2016). A Single Amino Acid Difference between Mouse and Human 5-Lipoxygenase Activating Protein (FLAP) Explains the Speciation and Differential Pharmacology of Novel FLAP Inhibitors. Journal of Biological Chemistry. 291(24). 12724–12731. 12 indexed citations
7.
Song, Jiao, Xuejun Liu, Tadimeti S. Rao, et al.. (2015). Phenotyping drug polypharmacology via eicosanoid profiling of blood. Journal of Lipid Research. 56(8). 1492–1500. 12 indexed citations
8.
Keith, John M., W. M. Jones, Mark S. Tichenor, et al.. (2015). Preclinical Characterization of the FAAH Inhibitor JNJ-42165279. ACS Medicinal Chemistry Letters. 6(12). 1204–1208. 47 indexed citations
9.
Keith, John M., W. M. Jones, Mark Seierstad, et al.. (2014). Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry Letters. 24(3). 737–741. 24 indexed citations
10.
Keith, John M., Natalie A. Hawryluk, Richard L. Apodaca, et al.. (2014). 1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry Letters. 24(5). 1280–1284. 11 indexed citations
11.
Karbarz, Mark J., Lin Luo, Leon Chang, et al.. (2008). Biochemical and Biological Properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a Mechanism-Based Inhibitor of Fatty Acid Amide Hydrolase. Anesthesia & Analgesia. 108(1). 316–329. 61 indexed citations
12.
Seierstad, Mark, Richard L. Apodaca, Sean M. Brown, et al.. (2008). Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH). Bioorganic & Medicinal Chemistry Letters. 18(6). 2109–2113. 25 indexed citations
13.
Palmer, James A., Emiliano S. Higuera, Leon Chang, & Sandra R. Chaplan. (2008). Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse. Neuroscience. 154(4). 1554–1561. 24 indexed citations
14.
Chang, Leon, Lin Luo, James A. Palmer, et al.. (2006). Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms. British Journal of Pharmacology. 148(1). 102–113. 139 indexed citations
15.
Luo, Ling, Leon Chang, Sean M. Brown, et al.. (2006). Role of peripheral hyperpolarization-activated cyclic nucleotide-modulated channel pacemaker channels in acute and chronic pain models in the rat. Neuroscience. 144(4). 1477–1485. 90 indexed citations
16.
17.
Swanson, Devin M., Adrienne E. Dubin, Chandra Shah, et al.. (2004). Identification and Biological Evaluation of 4-(3-Trifluoromethylpyridin-2-yl)piperazine-1-carboxylic Acid (5-Trifluoromethylpyridin-2-yl)amide, a High Affinity TRPV1 (VR1) Vanilloid Receptor Antagonist. Journal of Medicinal Chemistry. 48(6). 1857–1872. 144 indexed citations
18.
Bonhaus, Douglas W., Lee A. Flippin, Robert Greenhouse, et al.. (1999). RS‐127445: a selective, high affinity, orally bioavailable 5‐HT2B receptor antagonist. British Journal of Pharmacology. 127(5). 1075–1082. 95 indexed citations
19.
Jasper, Jeffrey R., John Lesnick, Leon Chang, et al.. (1998). Ligand Efficacy and Potency at Recombinant α2 Adrenergic Receptors. Biochemical Pharmacology. 55(7). 1035–1043. 144 indexed citations
20.
Bonhaus, Douglas W., et al.. (1998). Dual Activation and Inhibition of Adenylyl Cyclase by Cannabinoid Receptor Agonists: Evidence for Agonist-Specific Trafficking of Intracellular Responses. Journal of Pharmacology and Experimental Therapeutics. 287(3). 884–888. 197 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pietro Marini Breakdown of academic impact, for papers by Oscar Sasso Breakdown of academic impact, for papers by Barbara Malinowska Breakdown of academic impact, for papers by Xavier Nadal Breakdown of academic impact, for papers by Jenny L. Wilkerson Breakdown of academic impact, for papers by Gunnar Tiger Breakdown of academic impact, for papers by Susanna Tchilibon Breakdown of academic impact, for papers by Sherry Shu‐Jung Hu Breakdown of academic impact, for papers by Sharon Anavi‐Goffer Breakdown of academic impact, for papers by Jesse LoVerme
Rankless by CCL
2026